PET-MR can predict survival and response in advanced hepatocellular carcinoma patients treated with sorafenib

被引：0
|
作者：
Hwang, Jae-Pil [1 ]
Lim, Ilhan [1 ]
Han, Chul Ju [2 ]
Park, Su Cheol [2 ]
Kim, Young Han [3 ]
Park, Joon Yeun [1 ]
Kim, Kyeong Min [1 ]
Kim, Byung Il [1 ]
Choi, Chang Woon [1 ]
Lim, Sang Moo [1 ]
机构：
[1] Korea Canc Ctr Hosp, Nucl Med, Seoul, South Korea
[2] Korea Canc Ctr Hosp, Internal Med, Seoul, South Korea
[3] Korea Canc Ctr Hosp, Radiol, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early decrease in alfafetoprotein as a prognosis factor of response in patients with advanced hepatocellular carcinoma treated with sorafenib
    Maria Sanchez, Yolanda
    Ontanilla, Guillermo
    Teresa Ferrer, Maria
    Giraldez, Alvaro
    Manuel Sousa, Jose
    Manuel Pascasio, Juan
    HEPATOLOGY, 2016, 64 : 634A - 635A
  • [32] TUMOR NECROSIS AS A CORRELATE FOR RESPONSE IN SUBGROUP OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH SORAFENIB
    Abou-Alfa, G. K.
    Zhao, B.
    Capanu, M.
    Guo, P.
    Liu, F.
    Jacobs, G.
    Gansukh, B.
    Moscovici, M.
    Lentini, G.
    Schwartz, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 178 - 178
  • [33] The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Campani, C.
    Colagrande, S.
    Calistri, L.
    Dragoni, G.
    Lorini, C.
    Castellani, A.
    Marra, F.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E51 - E52
  • [34] The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Campani, Claudia
    Colagrande, Stefano
    Calistri, Linda
    Lorini, Chiara
    Castellani, Alessandro
    Marra, Fabio
    JOURNAL OF HEPATOLOGY, 2020, 73 : S896 - S897
  • [35] Factors Contributing to the Overall Survival in Patients with Hepatocellular Carcinoma Treated by Sorafenib
    Tsukui, Yuya
    Mochizuki, Hitoshi
    Hoshino, Yuji
    Kawakami, Satoshi
    Kuno, Toru
    Fukasawa, Yoshimitsu
    Iwamoto, Fumihiko
    Hirose, Sumio
    Yoshida, Takashi
    Hosoda, Kenji
    Suzuki, Youji
    Hosoda, Kazuhiko
    Kojima, Yuichiro
    Hirose, Yuichi
    Shindou, Kuniaki
    Matsuda, Masanori
    Yagawa, Syoji
    Tawara, Akio
    Kobayashi, Masashi
    Konishi, Toshiyuki
    Yamazaki, Takahisa
    Takahashi, Seiichiro
    Fujii, Hideki
    Enomoto, Nobuyuki
    Omata, Masao
    HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2536 - 2539
  • [36] Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma
    Williet, Nicolas
    Clavel, Lea
    Bourmaud, Aurelie
    Verot, Celine
    Bouarioua, Nadia
    Roblin, Xavier
    Merle, Philippe
    Phelip, Jean-Marc
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (09) : 1043 - 1049
  • [37] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
  • [38] Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
    Stras, Wojciech
    Gotlib, Joanna
    Malkowski, Piotr
    Wasiak, Dariusz
    Sliwczynski, Andrzej
    Panczyk, Mariusz
    Tronina, Olga
    Brzozowska, Melania
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [39] Changes of Cytokines in Cirrhosis Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
    Nagai, Hidenari
    Mukozu, Takanori
    Matui, Daigo
    Ogino, Yu
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S979 - S979
  • [40] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345